Vol. 63 No. 3 (2017), ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

Vol. 63 No. 3 (2017)

NUMERICAL COEFFICIENT FOR ENDOMETRIAL CANCER INDIVIDUAL RISK EVALUATION IN POSTMENOPAUSAL WOMEN

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2017-63-3-461-465

Published 01.03.2017

Lev Bershteyn⁺⁻
Dmitriy Vasilev⁺⁻
Tatyana Poroshina⁺⁻
Igor Berlev⁺⁻

Lev Bershteyn

N.N. Petrov Research Institute of Oncology

Dmitriy Vasilev

N.N. Petrov Research Institute of Oncology

Tatyana Poroshina

N.N. Petrov Research Institute of Oncology

Igor Berlev

N.N. Petrov Research Institute of Oncology

PDF (Русский)

Keywords

ENDOMETRIAL CANCER
POSTMENOPAUSE
RISK
PERSONIFICATION
NUMERICAL COEFFICIENT

How to Cite

Bershteyn, L., Vasilev, D., Poroshina, T., & Berlev, I. (2017). NUMERICAL COEFFICIENT FOR ENDOMETRIAL CANCER INDIVIDUAL RISK EVALUATION IN POSTMENOPAUSAL WOMEN. Voprosy Onkologii, 63(3), 461–465. https://doi.org/10.37469/0507-3758-2017-63-3-461-465

Abstract

Increased frequency of endometrial cancer (EC) since the beginning of this century exceeds that of breast cancer and to a large extent can be attributed to dynamics of parameters, which characterize hormonal and metabolic status of ill women and molecular genetic landscape of transforming endometrium. During the past few years there are suggested several options for a personalized assessment of the risk of EC. The aim of this article is to propose and justify own version of this score with the idea of its further not only retrospective but also prospective testing both in relation to the risk of developing endometrial cancer as well as an additional marker helping to predict tumor response to treatment.

https://doi.org/10.37469/0507-3758-2017-63-3-461-465

PDF (Русский)

References

Балтрукова А.Н., Берлев И.В., Берштейн Л.М. Сравнительная оценка гормонально-метаболического статуса больных раком эндометрия за последние пять десятилетий // Журнал акушерства и женских болезней. - 2016. - Т. LXY(1). - С. 9-16.

Балтрукова А.Н., Берштейн Л.М., Берлев И.В. Сдвиги менструальной и репродуктивной функции у больных раком эндометрия за последние 50 лет // Вестн. СЗГМУ им. И.И. Мечникова. - 2016. - Т. 8 (4). - С. 75-80.

Берштейн Л.М. Гетерогенность ожирения и рак: потенциальная роль бурой жировой ткани // Вопр. онкол. - 2012. - Т. 58 (4). - С. 464-472.

Берштейн Л.М., Берлев И.В., Васильев Д.А. и др. Ожирение и особенности рака эндометрия: меняется ли что-нибудь с годами? // Вопр.онкол. -2015. - Т. 61 (4). - С. 575-579.

Бохман Я.В. Руководство по онкогинекологии. - Л.: Медицина, 1989. - 464 с.

Бохман Я.В., Костина Л.И. О патогенетических вариантах рака тела матки // Вопр. онкол. - 1972. - Т. 18 (2). - С. 18-24.

Унанян А.Л., Сидорова И.С., Коган Е.А., Бабурин Д.В. Прогнозирование рака тела матки у женщин с гиперпластическими процессами в пременопа-узальном возрасте // Акушерство, гинекология и репродукция. - 2012. - № 2. - С. 18-24.

Чернышова А.Л. Прогноз и особенности течения рака эндометрия на фоне метаболического синдрома. Автореф. дисс. докт. мед. наук. - Томск, 2009.

Amant F, Moerman P, Neven P et al. Endometrial cancer // Lancet. - 2005. - Vol. 366 (9484). - P. 491-505.

Aune D, Navarro Rosenblatt DA, Chan DS et al. Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies // Ann Oncol. - 2015. - Vol. 26 (8). - P. 1635-1648.

Berstein L.M. Renovated (nondual) approach to endometrial cancer typing: endocrine and inflammatory issues // Future Oncol. - 2017. - Vol. 13 (2). - P. 109-112.

Berstein LM. Newborn macrosomy and cancer // Adv. Cancer Res. - 1988. - Vol. 50. - P. 231-278.

Berstein L.M., Poroshina T.E., Turkevich E.A. et al. Features of endometrial cancer in patients with ‘metabolically healthy' versus ‘standard' obesity: the decreasing frequency of metabolically healthy obesity // Future Sci. OA. - 2015. - Vol. 1 (4). - FSO68.

Boronow RC.Endometrial cancer: not a benign disease // Obstet. Gynecol. - 1976. - Vol. 47 (5). - P. 630-634.

Brown SB, Hankinson SE. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers // Steroids. - 2015. - Vol. 99 (Pt A). - P. 8-10.

Cancer Research UK, http://www.cancerresearchuk. org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer, доступ: февраль 2017.

Collaborative Group on Epidemiological Studies on Endometrial Cancer. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies // Lancet Oncol. - 2015. -Vol. 16 (9). - P. 1061-1070.

Esposito K, Chiodini P, Capuano A et al. Metabolic syndrome and endometrial cancer: a meta-analysis // Endocrine. - 2014. - Vol. 45 (1). - P. 28-36.

Gail MH, Brinton LA, Byar DP et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually // J. Natl. Cancer Inst. - 1989. - Vol. 81 (24). - P. 1879-1886.

Gail MH, Costantino JP, Bryant J et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer // J Natl Cancer Inst. - 1999. - Vol. 91 (21). - P. 1829-1846.

Grundker C, Gunthert AR, Emons G. Hormonal heterogeneity of endometrial cancer // Adv Exp Med Biol. - 2008. - Vol. 630. - P. 166-188.

Husing A., Dossus L., Ferrari P. et al. An epidemiological model for prediction of endometrial cancer risk in Europe // Eur. J. Epidemiol. - 2016. - Vol. 31 (1). - P. 51-60.

Kandoth C, Schultz N, Cancer Genome Atlas Research Network et al. Integrated genomic characterization of endometrial carcinoma // Nature. - 2013. - Vol. 497 (7447). - P 67-73.

Kitson SJ, Evans DG, Crosbie EJ. Identifying High-Risk Women for Endometrial Cancer Prevention Strategies: Proposal of an Endometrial Cancer Risk Prediction Model //Cancer Previo. Res. (Phila). - 2017. - Vol. 10 (1). - P. 1-13.

Lindemann K., Vatten L.J., Ellstr0m-Engh M., Eskild A. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study // Br. J. Cancer. - 2008. -Vol. 98 (9). - P. 1582-1585.

Mehnert J.M., Panda A., Zhong H. et al. Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer // J. Clin. Invest. - 2016. -Vol. 126 (6). - P. 2334-2340.

Murali R, Soslow RA, Weigelt B. Classification of endometrial carcinoma: more than two types // Lancet Oncol. - 2014. - Vol. 15 (7). - e268-278.

Pfeiffer RM, Park X Kreimer AR et al. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50y or older: derivation and validation from population-based cohort studies // PLoS Med. - 2013. -Vol. 10 (7). - e1001492.

Sivridis E., Giatromanolaki A. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma // J. Clin. Pathol. - 2004. - Vol. 57. - P. 840-844.

Sheikh MA, Althouse AD, Freese KF, et al. USA Endometrial Cancer Projections to 2030: should we be concerned? // Future Oncol. - 2014. - Vol. 10 (16). - P. 2561-2568.

Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach // Mod Pathol. - 2000. - Vol. 13 (3). - P. 295-308.

Tokmak A, Kokanali MK, Guzel AI et al. Polycystic ovary syndrome and risk of endometrial cancer: a mini-review // Asian Pac. J. Cancer Prev. - 2014. - Vol. 15 (17). - P. 7011-7014.

Tsilidis K.K., Kasimis J.C., Lopez D.S. et al. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies // BMJ. - 2015. - Vol. 350. -g7607.

Villavicencio A, Aguilar G, Acuna J. et al. The identification of two subgroups of obese women with differing endometrial proliferation levels: potential consequences in the development of endometrial cancer // Int. J. Obes. (Lond). - 2012. - Vol. 36 (7). - P. 1012-1015.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Yevgeniya Tsyrlina, Yelena Zhiltsova, Tatyana Poroshina, Irina Meshkova, Lev Bershteyn, Vladimir Semiglazov, N. Barash, OVARIAN CYSTS AND HYPERESTROGENIA AS A SIDE EFFECT OF TAMOXIFEN THERAPY IN BREAST CANCER PATIENTS OF REPRODUCTIVE AND POSTMENOPAUSAL AGE , Voprosy onkologii : Vol. 64 No. 1 (2018)
Tatyana Semiglazova, Yevgeniya Tsyrlina, Artem Poltoratskiy, Yekaterina Busko, Vladislav Semiglazov, Anna Artemeva, Sergey Ivanov, Lev Bershteyn, Vladimir Anisimov, Aleksey Belyaev, Vladimir Semiglazov, V. Kostorov, Aleksey Novik, Boris Kasparov, Mikhail Osipov, Petr Krivorotko, Veronika Klimenko, Garik Dashyan, Ruslan Paltuev, Yelena Zhiltsova, Tengiz Tabagua, Aleksandr Komyakhov, Kirill Nikolaev, Viktoriya Bashlyk, Roman Donskikh, V. Apollonova, MELATONIN AND METFORMIN IN NEOADJUVANT HORMONOTHERAPY IN LOCALLY ADVANCED BREAST CANCER , Voprosy onkologii : Vol. 64 No. 5 (2018)
Tatiana Gorodnova, Anna Sokolenko, Kh.B Kotiv , Alexandr Ivantsov, Maria Yakovleva , Olga Lavrinovich, Nikolay Mikaya, Zaur Ibragimov, Yurii Trifanov, Nikolay Bondarev , Olga Smirnova, Konstantin Guseinov, Elena Bakhidze, Irina Meshkova, Elena Konstantinova, Adel Urmancheeva, Igor Berlev, Alexei Belyaev, Evgeny Imyanitov, The prospective randomized trial evaluating the efficacy of the mitomycin C and cisplatin regimen (MP) versus standard first-line chemotherapy in patients with advanced BRCA1/2-associated ovarian cancer (NCT04747717) , Voprosy onkologii : Vol. 68 No. 5 (2022)
Tatyana Rogovskaya, Anna Sidoruk, Irina Meshkova, Yekaterina Nekrasova, Zaur Ibragimov, Igor Berlev, Adiliya Urmancheeva, LYMPHOCYSTS AFTER LAPAROSCOPIC AND OPEN HYSTERECTOMY WITH PELVIC LYMPHADENECTOMY FOR ENDOMETRIAL CANCER , Voprosy onkologii : Vol. 63 No. 3 (2017)
Elena Bakhidze, Elena, Aleksey Belyaev , Igor Berlev , Jan V. Bohman and his school. On the 90th anniversary of the birth of Professor Bohman, one of the most outstanding domestic gynecologic oncologists of the 20th century , Voprosy onkologii : Vol. 69 No. 2 (2023)
Tatyana Gorodnova, Nikolay Bondarev, Olga Lavrinovich, Nikolay Mikaya, Yelena Ulrikh, Adiliya Urmancheeva, Yevgeniy Imyanitov, Aleksey Karachun, Aleksey Belyaev, Olga Smirnova, Anna Sidoruk, Khristina Kotiv, Sergey Petrik, Anna Sokolenko, Aleksandr Ivantsov, Katran Guseynov, Zaur Ibragimov, Irina Meshkova, Yekaterina Nekrasova, Igor Berlev, CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER: A REVIEW OF LITERATURE AND ANALYSIS OF THE EXPERIENCE OF THE CLINIC FOR THIRTEEN YEARS , Voprosy onkologii : Vol. 64 No. 3 (2018)
Igor Berlev, Anna Sidoruk, Olga Smirnova, Nikolay Bondarev, Olga Lavrinovich, Nikolay Mikaya, Yelena Ulrikh, Adiliya Urmancheeva, M. Yakoveva, Yekaterina Nekrasova, Irina Meshkova, Aleksandr Ivantsov, Aleksey Belyaev, Aleksey Karachun, Tatyana Gorodnova, Andrey Domanskiy, Yuriy Pelipas, Katran Guseynov, Zaur Ibragimov, Anna Sokolenko, N. Matveeva, CYTOREDUCTIVE SURGERY WITH PERITONECTOMY IN PATIENTS WITH OVARIAN CANCER: TECHNICAL ASPECTS AND IMMEDIATE RESULTS , Voprosy onkologii : Vol. 64 No. 3 (2018)
Igor Berlev, Yu. Trifanov, Sergey Kanaev, Adiliya Urmancheeva, Nikolay Mikaya, Yevgeniya Bezhanova, Yekaterina Nekrasova, Gayk Mkrtchyan, Tatyana Rogovskaya, Pavel Krzhivitskiy, Sergey Novikov, Tatyana Gorodnova, Katran Guseynov, Zaur Ibragimov, Yelena Ulrikh, R. Akhmerov, POSSIBILITIES OF DETECTION OF SENTINEL LYMPH NODES IN ENDOMETRIAL CANCER BY RADIOISOTOPE AND FLUORESCENT (ICG) METHODS , Voprosy onkologii : Vol. 63 No. 2 (2017)
Igor Berlev, Yekaterina Nekrasova, Gayk Mkrtchyan, Yevgeniya Bezhanova, Katran Guseynov, Yelena Ulrikh, Viktoriya Bashlyk, Anna Artemeva, Tatyana Semiglazova, Aleksandra Kondakova, Andrey Mishchenko, Nikolay Mikaya, Adiliya Urmancheeva, Nikolay Bondarev, O. Smirnova, DOSE-INTENSIVE NEOADJUVANT CHEMOTHERAPY IN COMBINED TREATMENT FOR LOCALLY ADVANCED CERVICAL CANCER: THE EXPERIENCE AND PERSPECTIVES , Voprosy onkologii : Vol. 63 No. 4 (2017)
Olga Lavrinovich, Mariia Iakovleva, Igor Berlev, Adel Urmancheeva, Fertility preservation surgeries and reproductive technologies in patients with early ovarian cancer and borderline tumors , Voprosy onkologii : Vol. 67 No. 4 (2021)

1 2 3 > >>